Microbiome predictors of dysbiosis and vre decolonization in patients with recurrent c. Difficile infections in a multi-center retrospective study

Marina Santiago, Lindsay Eysenbach, Jessica Allegretti, Olga Aroniadis, Lawrence J. Brandt, Monika Fischer, Ari Grinspan, Colleen Kelly, Casey Morrow, Martin Rodriguez, Majdi Osman, Zain Kassam, Mark B. Smith, Sonia Timberlake

Research output: Contribution to journalArticle

Abstract

The gastrointestinal microbiome is intrinsically linked to the spread of antibiotic resistance. Antibiotic treatment puts patients at risk for colonization by opportunistic pathogens like vancomycin resistant Enterococcus and Clostridioides difficile by destroying the colonization resistance provided by the commensal microbiota. Once colonized, the host is at a much higher risk for infection by that pathogen. Furthermore, we know that microbiome community differences are associated with disease states, but we do not have a good understanding of how we can use these changes to classify different patient populations. To that end, we have performed a multicenter retrospective analysis on patients who received fecal microbiota transplants to treat recurrent Clostridioides difficile infection. We performed 16S rRNA gene sequencing on fecal samples collected as part of this study and used these data to develop a microbiome disruption index. Our microbiome disruption index is a simple index that is predictive across cohorts, indications, and batch effects. We are able to classify pre-fecal transplant vs post-fecal transplant samples in patients with recurrent C. difficile infection, and we are able to predict, using previously-published data from a cohort of patients receiving hematopoietic stem cell transplants, which patients would go on to develop bloodstream infections. Finally, we also identified patients in this cohort that were initially colonized with vancomycin resistant Enterococcus and that 92% (11/12) were decolonized after the transplant, but the microbiome disruption index was unable to predict such decolonization. We, however, were able to compare the relative abundance of different taxa between the two groups, and we found that increased abundance of Entero bacteriaceae predicts whether patients were colonized with vancomycin resistant Enterococcus. This work is an early step towards a better understanding of how microbiome predictors can be used to help improve patient care and patient outcomes.

Original languageEnglish (US)
Pages (from-to)1-18
Number of pages18
JournalAIMS Microbiology
Volume5
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Dysbiosis
Microbiota
Retrospective Studies
Infection
Transplants
Microbial Drug Resistance
Hematopoietic Stem Cells
rRNA Genes
Patient Care
Anti-Bacterial Agents

Keywords

  • Clostridioides difficile
  • Fecal microbiota transplant
  • Microbiome
  • Vancomycin resistant Enterococcus

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

Microbiome predictors of dysbiosis and vre decolonization in patients with recurrent c. Difficile infections in a multi-center retrospective study. / Santiago, Marina; Eysenbach, Lindsay; Allegretti, Jessica; Aroniadis, Olga; Brandt, Lawrence J.; Fischer, Monika; Grinspan, Ari; Kelly, Colleen; Morrow, Casey; Rodriguez, Martin; Osman, Majdi; Kassam, Zain; Smith, Mark B.; Timberlake, Sonia.

In: AIMS Microbiology, Vol. 5, No. 1, 01.01.2019, p. 1-18.

Research output: Contribution to journalArticle

Santiago, M, Eysenbach, L, Allegretti, J, Aroniadis, O, Brandt, LJ, Fischer, M, Grinspan, A, Kelly, C, Morrow, C, Rodriguez, M, Osman, M, Kassam, Z, Smith, MB & Timberlake, S 2019, 'Microbiome predictors of dysbiosis and vre decolonization in patients with recurrent c. Difficile infections in a multi-center retrospective study', AIMS Microbiology, vol. 5, no. 1, pp. 1-18. https://doi.org/10.3934/microbiol.2019.1.1
Santiago, Marina ; Eysenbach, Lindsay ; Allegretti, Jessica ; Aroniadis, Olga ; Brandt, Lawrence J. ; Fischer, Monika ; Grinspan, Ari ; Kelly, Colleen ; Morrow, Casey ; Rodriguez, Martin ; Osman, Majdi ; Kassam, Zain ; Smith, Mark B. ; Timberlake, Sonia. / Microbiome predictors of dysbiosis and vre decolonization in patients with recurrent c. Difficile infections in a multi-center retrospective study. In: AIMS Microbiology. 2019 ; Vol. 5, No. 1. pp. 1-18.
@article{4014cd68b9d14c169978cc98a75fa10d,
title = "Microbiome predictors of dysbiosis and vre decolonization in patients with recurrent c. Difficile infections in a multi-center retrospective study",
abstract = "The gastrointestinal microbiome is intrinsically linked to the spread of antibiotic resistance. Antibiotic treatment puts patients at risk for colonization by opportunistic pathogens like vancomycin resistant Enterococcus and Clostridioides difficile by destroying the colonization resistance provided by the commensal microbiota. Once colonized, the host is at a much higher risk for infection by that pathogen. Furthermore, we know that microbiome community differences are associated with disease states, but we do not have a good understanding of how we can use these changes to classify different patient populations. To that end, we have performed a multicenter retrospective analysis on patients who received fecal microbiota transplants to treat recurrent Clostridioides difficile infection. We performed 16S rRNA gene sequencing on fecal samples collected as part of this study and used these data to develop a microbiome disruption index. Our microbiome disruption index is a simple index that is predictive across cohorts, indications, and batch effects. We are able to classify pre-fecal transplant vs post-fecal transplant samples in patients with recurrent C. difficile infection, and we are able to predict, using previously-published data from a cohort of patients receiving hematopoietic stem cell transplants, which patients would go on to develop bloodstream infections. Finally, we also identified patients in this cohort that were initially colonized with vancomycin resistant Enterococcus and that 92{\%} (11/12) were decolonized after the transplant, but the microbiome disruption index was unable to predict such decolonization. We, however, were able to compare the relative abundance of different taxa between the two groups, and we found that increased abundance of Entero bacteriaceae predicts whether patients were colonized with vancomycin resistant Enterococcus. This work is an early step towards a better understanding of how microbiome predictors can be used to help improve patient care and patient outcomes.",
keywords = "Clostridioides difficile, Fecal microbiota transplant, Microbiome, Vancomycin resistant Enterococcus",
author = "Marina Santiago and Lindsay Eysenbach and Jessica Allegretti and Olga Aroniadis and Brandt, {Lawrence J.} and Monika Fischer and Ari Grinspan and Colleen Kelly and Casey Morrow and Martin Rodriguez and Majdi Osman and Zain Kassam and Smith, {Mark B.} and Sonia Timberlake",
year = "2019",
month = "1",
day = "1",
doi = "10.3934/microbiol.2019.1.1",
language = "English (US)",
volume = "5",
pages = "1--18",
journal = "AIMS Microbiology",
issn = "2471-1888",
publisher = "AIMS Press",
number = "1",

}

TY - JOUR

T1 - Microbiome predictors of dysbiosis and vre decolonization in patients with recurrent c. Difficile infections in a multi-center retrospective study

AU - Santiago, Marina

AU - Eysenbach, Lindsay

AU - Allegretti, Jessica

AU - Aroniadis, Olga

AU - Brandt, Lawrence J.

AU - Fischer, Monika

AU - Grinspan, Ari

AU - Kelly, Colleen

AU - Morrow, Casey

AU - Rodriguez, Martin

AU - Osman, Majdi

AU - Kassam, Zain

AU - Smith, Mark B.

AU - Timberlake, Sonia

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The gastrointestinal microbiome is intrinsically linked to the spread of antibiotic resistance. Antibiotic treatment puts patients at risk for colonization by opportunistic pathogens like vancomycin resistant Enterococcus and Clostridioides difficile by destroying the colonization resistance provided by the commensal microbiota. Once colonized, the host is at a much higher risk for infection by that pathogen. Furthermore, we know that microbiome community differences are associated with disease states, but we do not have a good understanding of how we can use these changes to classify different patient populations. To that end, we have performed a multicenter retrospective analysis on patients who received fecal microbiota transplants to treat recurrent Clostridioides difficile infection. We performed 16S rRNA gene sequencing on fecal samples collected as part of this study and used these data to develop a microbiome disruption index. Our microbiome disruption index is a simple index that is predictive across cohorts, indications, and batch effects. We are able to classify pre-fecal transplant vs post-fecal transplant samples in patients with recurrent C. difficile infection, and we are able to predict, using previously-published data from a cohort of patients receiving hematopoietic stem cell transplants, which patients would go on to develop bloodstream infections. Finally, we also identified patients in this cohort that were initially colonized with vancomycin resistant Enterococcus and that 92% (11/12) were decolonized after the transplant, but the microbiome disruption index was unable to predict such decolonization. We, however, were able to compare the relative abundance of different taxa between the two groups, and we found that increased abundance of Entero bacteriaceae predicts whether patients were colonized with vancomycin resistant Enterococcus. This work is an early step towards a better understanding of how microbiome predictors can be used to help improve patient care and patient outcomes.

AB - The gastrointestinal microbiome is intrinsically linked to the spread of antibiotic resistance. Antibiotic treatment puts patients at risk for colonization by opportunistic pathogens like vancomycin resistant Enterococcus and Clostridioides difficile by destroying the colonization resistance provided by the commensal microbiota. Once colonized, the host is at a much higher risk for infection by that pathogen. Furthermore, we know that microbiome community differences are associated with disease states, but we do not have a good understanding of how we can use these changes to classify different patient populations. To that end, we have performed a multicenter retrospective analysis on patients who received fecal microbiota transplants to treat recurrent Clostridioides difficile infection. We performed 16S rRNA gene sequencing on fecal samples collected as part of this study and used these data to develop a microbiome disruption index. Our microbiome disruption index is a simple index that is predictive across cohorts, indications, and batch effects. We are able to classify pre-fecal transplant vs post-fecal transplant samples in patients with recurrent C. difficile infection, and we are able to predict, using previously-published data from a cohort of patients receiving hematopoietic stem cell transplants, which patients would go on to develop bloodstream infections. Finally, we also identified patients in this cohort that were initially colonized with vancomycin resistant Enterococcus and that 92% (11/12) were decolonized after the transplant, but the microbiome disruption index was unable to predict such decolonization. We, however, were able to compare the relative abundance of different taxa between the two groups, and we found that increased abundance of Entero bacteriaceae predicts whether patients were colonized with vancomycin resistant Enterococcus. This work is an early step towards a better understanding of how microbiome predictors can be used to help improve patient care and patient outcomes.

KW - Clostridioides difficile

KW - Fecal microbiota transplant

KW - Microbiome

KW - Vancomycin resistant Enterococcus

UR - http://www.scopus.com/inward/record.url?scp=85064074049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064074049&partnerID=8YFLogxK

U2 - 10.3934/microbiol.2019.1.1

DO - 10.3934/microbiol.2019.1.1

M3 - Article

AN - SCOPUS:85064074049

VL - 5

SP - 1

EP - 18

JO - AIMS Microbiology

JF - AIMS Microbiology

SN - 2471-1888

IS - 1

ER -